The HCPLive plaque psoriasis page is a resource for medical news and expert insights on psoriasis. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for psoriatic disease, and more.
April 24th 2024
A new study found intensive topical therapy improves deep sleep and REM sleep for patients with psoriasis and atopic dermatitis after 2 weeks.
Acne Scarring: Chemical Peels, Microneedling, Treatment Risks and Considerations
During this conference talk, Dr. Nicole Gunasekera spoke about options for acne scar treatments such as chemical peels and microneedling, as well as special considerations for richly-pigmented skin.
Deep-Learning Algorithm Shows Positive Results in Classifying Dermatologic Conditions Through Images
This new tool, using an automated analysis of different parts of the body, could help clinicians to address previously unmet needs for treatment in conditions such as psoriasis.
Study Suggests Ustekinumab Should Be First-Line Therapy for Psoriasis Patients with Trisomy 21
This new research may help clinicians in their guidance of patients with T21, though the data may require future studies to help examine immune parameters of the clinical outcomes.
Patients with Alopecia Areata Show Higher Prevalence of Autoimmune, Inflammatory Diseases
Alopecia areata patients had higher rates of diseases including psoriasis, allergic rhinitis, asthma, and atopic dermatitis, highlighting the burden of comorbidities on patients in the US.
Early Guselkumab for Psoriasis: Increased Super-Responder Likelihood in Short Disease Duration
Early intervention was shown to lead to better clinical responses, results which could translate to long-term improvements in psoriasis and sustained maintenance of response after withdrawal.
Strong Long-Term Trial Data for Adalimumab Observed for HS Patients in Real World Settings
In the results of this final analysis, the hidradenitis suppurativa drug was found to be well tolerated in patients regardless of either differing demographics or clinical characteristics.
4 Psoriasis Biosimilars Showing No Major Differences with Originators in Efficacy, Safety
These 4 treatments and their biosimilars show no significant differences, though future studies may be necessary to assess long-term efficacy and safety of biosimilars in treating psoriasis.
Psoriasis Found to Exhibit Altered Cellular Clusters, Higher Gene Activity in Metabolic Pathways
This new research into psoriasis and its systemic effects and comorbidities may be used to identify the mechanisms which affect skin inflammation in a single area and effects on other organs.